{"id":62721,"date":"2026-06-10T13:31:55","date_gmt":"2026-06-10T04:31:55","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/2929-20260610-01_wp_basic\/"},"modified":"2026-07-12T11:28:10","modified_gmt":"2026-07-12T02:28:10","slug":"2929-20260610-01_wp_basic","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/","title":{"rendered":"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP)"},"content":{"rendered":"","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2929","jir_company_name":"PharmaFoods Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-06-10","jir_source_link":"[Placeholder]","jir_short_summary":"Consolidated results for the third quarter of the fiscal year ending July 2026: net sales of 48,455 million yen (up 3.7% year over year), operating loss of 1,430 million yen, ordinary loss of 1,545 million yen, and net loss attributable to owners of the parent of 1,061 million yen. Full-year forecast unchanged. Initiatives for creating new value, new products, and overseas expansion are being advanced. R&D expenses are 1,166 million yen, advertising and promotional expenses are 30,061 million yen.","jir_summary":"### Business Overview\nPharmaFoods is advancing new value creation based on Mid-Term Management Plan 2026. Strengthening R&D including the development of new electrode materials following the eggshell membrane material \"ovoveil.\" In the field of drug discovery, CasMab antibodies have been licensed from Tohoku University, and Kadashiru (Kadasiru) treatment development is progressing. Expansion of sales channels centered in North America and preparation for GRAS certification are ongoing. Although sales are increasing due to new products and channels, operating and ordinary profits remain negative during the period. Full-year forecast unchanged.\n\n### Trends by Segment and Financial Impact\nBiomedicals: sales of 230 million yen, segment loss of 473 million yen. BtoB: sales of 5,560 million yen, segment income of 858 million yen. BtoC: sales of 42,734 million yen, segment loss of 342 million yen. In total, advertising and promotional expenses and new product launches press margins, while brand strengthening such as the Newmo series sustains sales growth. Cash and cash equivalents are 9,057 million yen (against the previous fiscal year end).","jir_financial_highlights":"Sales: 48,555 million yen\nOperating loss: -1,430 million yen\nOrdinary loss: -1,545 million yen\nNet loss attributable to owners of the parent: -1,061 million yen\nR&D expenses: 1,116 million yen\nAdvertising and promotional expenses: 30,061 million yen","jir_category":"Financial Results","jir_hashtags":"#PharmaFoods, #IR, #JapanStocks","jir_key_figures":"Sales: 48,555 million yen\nOperating loss: \u25b31,430 million yen\nOrdinary loss: \u25b31,545 million yen\nNet loss attributable to owners of the parent: \u25b31,061 million yen\nR&D expenses: 1,116 million yen","jir_meta_title":"\u3010PharmaFoods\u3011Q3 FY2026 Results Highlights | Sales in the 4.6x xx billion range with flat trend, continued losses","jir_meta_description":"Key points from PharmaFoods' Q3 FY2026 results. Sales are 48,555 million yen, operating loss 1,430 million yen, ordinary loss 1,545 million yen. Progress in new value creation and drug discovery\/new products, full-year forecast unchanged.","jir_og_title":"PharmaFoods Q3 Results | Sales Up, but Loss Continues","jir_og_description":"PharmaFoods' Q3 results. Strengthening new products and overseas expansion; full-year forecast unchanged.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_title\": \"\u58f2\u4e0a\u9ad8\u63a8\u79fb\", \"jir_chart_id\": \"revenue_trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"\u524d\u671f\u7b2c3\u56db\u534a\u671f\\\",\\\"\u5f53\u671f\u7b2c3\u56db\u534a\u671f\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"\u58f2\u4e0a\u9ad8\\\",\\\"data\\\":[466? ,48555],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{}}\"}, {\"jir_chart_title\": \"\u55b6\u696d\u640d\u5931\u63a8\u79fb\", \"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"\u524d\u671f\u7b2c3\u56db\u534a\u671f\\\",\\\"\u5f53\u671f\u7b2c3\u56db\u534a\u671f\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"\u55b6\u696d\u640d\u5931\\\",\\\"data\\\":[-217,-1430],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{}}\"}, {\"jir_chart_title\": \"\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u58f2\u4e0a\u9ad8\", \"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"BtoB\\\",\\\"BtoC\\\",\\\"\u30d0\u30a4\u30aa\u30e1\u30c7\u30a3\u30ab\u30eb\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"\u58f2\u4e0a\u9ad8\\\",\\\"data\\\":[5560,42734,239],\\\"backgroundColor\\\":[\\\"#4dc9f6\\\",\\\"#f67019\\\",\\\"#e3e226\\\"]}]},\\\"options\\\":{}}\"}, {\"jir_chart_title\": \"\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u5229\u76ca\", \"jir_chart_id\": \"margin_analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"BtoB\\\",\\\"BtoC\\\",\\\"\u30d0\u30a4\u30aa\u30e1\u30c7\u30a3\u30ab\u30eb\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"\u30bb\u30b0\u30e1\u30f3\u30c8\u5229\u76ca\uff08\u640d\u5931\uff09\\\",\\\"data\\\":[882,-342,-473],\\\"backgroundColor\\\":[\\\"#4dc9f6\\\",\\\"#f67019\\\",\\\"#e3e226\\\"]}]},\\\"options\\\":{}}\"}, {\"jir_chart_title\": \"\u901a\u671f\u4e88\u60f3\u3068\u5b9f\u7e3e\", \"jir_chart_id\": \"guidance_comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"\u58f2\u4e0a\u9ad8\\\",\\\"\u55b6\u696d\u5229\u76ca\\\",\\\"\u7d4c\u5e38\u5229\u76ca\\\",\\\"\u89aa\u4f1a\u793e\u682a\u4e3b\u306b\u5e30\u5c5e\u3059\u308b\u5f53\u671f\u7d14\u5229\u76ca\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"\u901a\u671f\u4e88\u60f3\\\",\\\"data\\\":[67000,2000,2000,1500],\\\"borderColor\\\":\\\"#36a2eb\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"\u5b9f\u7e3e\\\",\\\"data\\\":[48555,-1430,-1545,-1061],\\\"borderColor\\\":\\\"#ff6384\\\",\\\"fill\\\":false}]},\\\"options\\\":{}}\"}]","ir_related_company":57922,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-62721","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP) - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/\",\"name\":\"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP) - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-10T04:31:55+00:00\",\"dateModified\":\"2026-07-12T02:28:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP) - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/","url":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/","name":"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP) - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-10T04:31:55+00:00","dateModified":"2026-07-12T02:28:10+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-2929\/ir\/2929-20260610-01_wp_basic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending July 2026 (Japanese GAAP)"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"57922","title":"(\u682a)\u30d5\u30a1\u30fc\u30de\u30d5\u30fc\u30ba","ticker":"2929"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=62721"}],"version-history":[{"count":1,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62721\/revisions"}],"predecessor-version":[{"id":78897,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/62721\/revisions\/78897"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=62721"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=62721"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=62721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}